BOSTON – May 30, 2023 – Andrew (A.J.) Tibbetts, shareholder at global law firm Greenberg Traurig, LLP, will moderate a panel, “IP for AI: Expanding a Biopharma IP Portfolio to Protect AI and Data Innovations,” at the 2023 BIO International Convention June 6.
The panel will discuss various intellectual property (IP) options for protecting investments and developments in artificial intelligence (AI), software, and data science in the biopharma industry, for small, mid-size, and large companies, as well as founders, executives, and counsel in biopharma.
Tibbetts, an IP & Technology shareholder in the firm’s Boston office, leverages prior experience as a software engineer to provide practical intellectual property strategy counseling on matters related to software-implemented tech across a range of industries, from networking, fintech, and natural language processing through to life sciences, artificial intelligence, medical records, and medical devices. He advises a wide array of clients on intellectual property strategies, ranging from international and publicly traded companies and large research institutions to small and growing companies. He serves on the board of directors of MassMEDIC, helping support digital health efforts in the New England area.